Recent Activity

Loading...

HRMY

Harmony Biosciences Holdings, Inc. · NASDAQ

Performance

-7.19%

1W

-2.52%

1M

-14.14%

3M

+12.35%

6M

-10.12%

YTD

-18.29%

1Y

Profile

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Investment Analysis Report: HRMY

Overview

HRMY is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $1.98 billion. The company's financial data provides insights into its performance over the past three years, including balance sheet, income statement, and cash flow statement information. In this ...

See more ...

Technical Analysis of HRMY 2024-05-10

Overview:

In analyzing the technical indicators for HRMY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...

See more ...

Recent News & Updates